About Quincy Bioscience
Quincy Bioscience is a company based in Madison (United States) founded in 2004. Quincy Bioscience has raised $5.18 million across 2 funding rounds from investors including Capitala Group. The company has 78 employees as of November 30, 2021. Quincy Bioscience offers products and services including Prevagen. Quincy Bioscience operates in a competitive market with competitors including First Person Group, BrainGear, Sevo Nutraceuticals, Procera Health and Senescence, among others.
- Headquarter Madison, United States
- Employees 78 as on 30 Nov, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.18 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
- Investors
-
Employee Count
78
as on Nov 30, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quincy Bioscience
Quincy Bioscience offers a comprehensive portfolio of products and services, including Prevagen.
Over-the-counter product for supporting memory and brain health.
Funding Insights of Quincy Bioscience
Quincy Bioscience has successfully raised a total of $5.18M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Quincy Bioscience
Quincy Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Capitala Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global multi-sector investments are managed by the private equity firm.
|
Locked | Locked | Locked |
Investor details for Quincy Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quincy Bioscience
Investment portfolio details for Quincy Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Quincy Bioscience
Detailed financials for Quincy Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quincy Bioscience Comparisons
Peer comparison for Quincy Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quincy Bioscience
Quincy Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as First Person Group, BrainGear, Sevo Nutraceuticals, Procera Health and Senescence, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Functional mushroom ingredients for mental health are supplied.
|
|
| Locked | Locked | Locked |
Nutrient supplements for brain health are developed.
|
|
| Locked | Locked | Locked |
Science-based cognitive health nutraceuticals are licensed and commercialized.
|
|
| Locked | Locked | Locked |
Nutritional products for brain health and cognitive function are provided.
|
|
| Locked | Locked | Locked |
Develops nutritional and therapeutic products for cognitive health, performance, and neurodegenerative diseases.
|
Detailed competitors of Quincy Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quincy Bioscience
Complete news archive for Quincy Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quincy Bioscience
Quincy Bioscience was founded in 2004 and raised its 1st funding round 5 years after it was founded.
Quincy Bioscience is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Quincy Bioscience is a funded company, having raised a total of $5.18M across 2 funding rounds to date.
As of Nov 30, 2021, the latest employee count at Quincy Bioscience is 78.
Quincy Bioscience was founded in 2004 in Madison, United States, as a biotechnology firm. Novel technologies are discovered, developed, and commercialized to address cognitive issues, including mild memory loss associated with aging. Operations center on impaired calcium homeostasis, with products utilizing the patented protein Apoaequorin, a calcium-binding protein sourced from jellyfish. Focus remains on supporting cognitive function through these innovations.
Quincy Bioscience's top competitors include First Person Group, Procera Health and BrainGear.
Quincy Bioscience offers Prevagen.
Quincy Bioscience has 1 investor. Key investors include Capitala Group.